Pravin Dugel
Ophthalmology · Phoenix, AZNPI 1780686766
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $113,528 of the $175,814 with a category attached, or 64.6%. It is spread thinly across 19 manufacturers, the largest accounting for just 19.8%. Among ophthalmology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $1112.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$35K
- Alcon Research LLC$24K
- Novartis$23K
- Novartis Pharma AG$19K
- Chugai Pharmaceutical Co., Ltd.$17K
- F. Hoffmann-la Roche AG$13K
- plus $46K from 13 others
Across 34 payments — averaging $9042.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$223K
- Novartis$81K
- F. Hoffmann-la Roche AG$4K
What the payments were for
- Royalty or licence$24,04914%
- Consulting fees$113,52865%
- Speaking & faculty fees$15,7399%
- Travel & lodging$17,07310%
- Food & beverage$5,3083%
- Education$1180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $34,835 |
| Alcon Research LLC | 1 | $24,049 |
| Novartis | 46 | $22,624 |
| Novartis Pharma AG | 6 | $18,628 |
| Chugai Pharmaceutical Co., Ltd. | 6 | $16,813 |
| F. Hoffmann-la Roche AG | 6 | $12,541 |
| Thrombogenics, Inc. | 2 | $10,000 |
| Merck | 6 | $7,986 |
| Genentech, Inc. | 6 | $6,282 |
| Boehringer Ingelheim | 9 | $6,281 |
| Glaukos Corporation | 8 | $5,000 |
| Eyepoint US, Inc. | 6 | $4,133 |
| Boehringer Ingelheim International GmbH | 2 | $2,400 |
| Daiichi Sankyo Company LTD | 3 | $1,975 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $1,828 |
| Alcon | 4 | $235 |
| Carl Zeiss Meditec, Inc. | 2 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Genentech USA, Inc. | 5 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$29,231
- NGENUITY$24,049
- RTH258A_BEOVU_OPHTHALMOLOGY$18,400
- BEOVU$12,509
- Jetrea$10,000
- Lucentis$6,187
- BUPARLISIB$5,497
- OZURDEX$3,899
- EYP-1901$3,200
- VITESSE$1,700
- OPHTHALMIC INSTRUMENTS$1,700
- YUTIQ$800
- iStent inject Trabecular Micro-Bypass Stent System$758
- iStent Trabecular Micro-Bypass Stent System$258
- Constellation$104
How this compares
$175,814 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.
Other ophthalmology in Phoenix
- Nishi ShahPhoenix$92K
- Karim JamalPhoenix$72K
- Benjamin HellerPhoenix$41K
- Neal PalejwalaPhoenix$33K
- Joshua DuncanPhoenix$30K
- Sachin MehtaPhoenix$23K
- Daniel ChurginPhoenix$15K
- John CasonPhoenix$14K
- Sujit IttyPhoenix$14K
- Elahhe AfkhamnejadPhoenix$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.